The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Recent Advances in miRNA Delivery Systems
Open accessAbstract
MicroRNAs (miRNAs) represent a family of short non-coding regulatory RNA molecules that are produced in a tissue and time-specific manner to orchestrate gene expression post-transcription. MiRNAs hybridize to target mRNA(s) to induce translation repression or mRNA degradation. Functional studies have demonstrated that miRNAs are engaged in virtually every physiological process and, consequently, miRNA dysregulations have been linked to multiple human pathologies. Thus, miRNA mimics and anti-miRNAs that restore miRNA expression or downregulate aberrantly expressed miRNAs, respectively, are highly sought-after therapeutic strategies for effective manipulation of miRNA levels. In this regard, carrier vehicles that facilitate proficient and safe delivery of miRNA-based therapeutics are fundamental to the clinical success of these pharmaceuticals. Here, we highlight the strengths and weaknesses of current state-of-the-art viral and non-viral miRNA delivery systems and provide perspective on how these tools can be exploited to improve the outcomes of miRNA-based therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
miRBase: from microRNA sequences to function
Kozomara, A., Birgaoanu, M., & Griffiths-Jones, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1141 · Cited by 4,843
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Exosomes – vesicular carriers for intercellular communication
Simons, M., & Raposo, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.007 · Cited by 2,351
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000610 · Cited by 1,334
Hammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,284
Olsen, P. H., & Ambros, V. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9523 · Cited by 1,234
Molecular Mechanisms of RNA Interference
Wilson, R. C., & Doudna, J. A. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130404 · Cited by 1,076
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Distribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930 · cited 1×
“In contrast to RVs that can only access the host chromosome when the nuclear membrane is dismantled during mitosis, LVs can actively translocate across an intact nuclear membrane via the nuclear pores and, thereby, can target both quiescent and non-quiescent cells [72].”
BackgroundGene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z. G., & Chopp, M. (2012) · Stem Cells · doi:10.1002/stem.1129 · Cited by 895
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
RNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
Chakraborty, C., Sharma, A. R., Sharma, G., Doss, C. G. P., & Lee, S.-S. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.06.005 · Cited by 731
Mesoporous silica nanoparticles in medicine—Recent advances
Mamaeva, V., Sahlgren, C., & Lindén, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 707
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L. S., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1216 · Cited by 701
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Lou, G., Song, X., Yang, F., Wu, S., Wang, J., Chen, Z., & Liu, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0220-7 · Cited by 651
Zylberberg, C., & Matosevic, S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1177136 · Cited by 627
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
The Promise of MicroRNA Replacement Therapy
Bader, A. G., Brown, D., & Winkler, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2010 · Cited by 617
Zhao, C., Sun, G., Li, S., & Shi, Y. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1576 · Cited by 578
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
Zhang, Y., Wang, Z., & Gemeinhart, R. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.015 · Cited by 535
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Regression of murine lung tumors by the let-7 microRNA
Trang, P., Medina, P. P., Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Homer, R., Brown, D., Bader, A. G., Weidhaas, J. B., et al. (2010) · Oncogene · doi:10.1038/onc.2009.445 · Cited by 500
Mir-34: A New Weapon Against Cancer?
Misso, G., Di Martino, M. T., De Rosa, G., Farooqi, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 498
Side effects of retroviral gene transfer into hematopoietic stem cells
Baum, C., Düllmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A., & von Kalle, C. (2003) · Blood · doi:10.1182/blood-2002-07-2314 · Cited by 435
Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1
Morel, L., Regan, M., Higashimori, H., Ng, S. K., Esau, C., Vidensky, S., Rothstein, J., & Yang, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410944 · Cited by 430
MicroRNA in cardiovascular biology and disease
Wojciechowska, A., Osiak, A., & Kozar-Kamińska, K. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/62915 · Cited by 418
Poeschla, E. M., Wong-Staal, F., & Looney, D. J. (1998) · Nature Medicine · doi:10.1038/nm0398-354 · Cited by 416
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ibrahim, A. F., Weirauch, U., Thomas, M., Grünweller, A., Hartmann, R. K., & Aigner, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4645 · Cited by 400
Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C. V., Zhao, Y., Reynolds, S., Cheng, H., Rupaimoole, R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.020 · Cited by 394
Cationic lipid–DNA complexes in gene delivery: from biophysics to biological applications
Pedroso de Lima, M. C., Simões, S., Pires, P., Faneca, H., & Düzgüneş, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00110-7 · Cited by 365
Drug Delivery with Extracellular Vesicles: From Imagination to Innovation
de Jong, O. G., Kooijmans, S. A. A., Murphy, D. E., Jiang, L., Evers, M. J. W., Sluijter, J. P. G., Vader, P., & Schiffelers, R. M. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00109 · Cited by 361
Chen, S., Tang, Y., Liu, Y., Zhang, P., Lv, L., Zhang, X., Jia, L., & Zhou, Y. (2019) · Cell Proliferation · doi:10.1111/cpr.12669 · Cited by 344
Jäger, M., Schubert, S., Ochrimenko, S., Fischer, D., & Schubert, U. S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35146c · Cited by 341
Sluijter, J. P. G., van Mil, A., van Vliet, P., Metz, C. H. G., Liu, J., Doevendans, P. A., & Goumans, M.-J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197434 · Cited by 325
A Small Viral RNA Is Required for in Vitro Packaging of Bacteriophage φ29 DNA
Guo, P., Erickson, S., & Anderson, D. (1987) · Science · doi:10.1126/science.3107124 · Cited by 312
(2013) · PubMed · Cited by 308
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Jiang, M., Wang, H., Jin, M., Yang, X., Ji, H., Jiang, Y., Zhang, H., Wu, F., Wu, G., Lai, X., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490078 · Cited by 305
Silica-based nanoparticles for biomedical applications
Bitar, A., Ahmad, N. M., Fessi, H., & Elaissari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.014 · Cited by 288
Liu, Y., Lai, L., Chen, Q., Song, Y., Xu, S., Ma, F., Wang, X., Wang, J., Yu, H., Cao, X., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103505 · Cited by 272
Wang, N., Chen, C., Yang, D., Liao, Q., Luo, H., Wang, X., Zhou, F., Yang, X., Yang, J., Zeng, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.023 · Cited by 266
GAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3503 · Cited by 262
Luo, Q., Guo, D., Liu, G., Chen, G., Hang, M., & Jin, M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485949 · Cited by 260
Banales, J. M., Sáez, E., Úriz, M., Sarvide, S., Urribarri, A. D., Splinter, P., Tietz Bogert, P. S., Bujanda, L., Prieto, J., Medina, J. F., et al. (2012) · Hepatology · doi:10.1002/hep.25691 · Cited by 250
‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing
Sundaram, G. M., Common, J. E. A., Gopal, F. E., Srikanta, S., Lakshman, K., Lunny, D. P., Lim, T. C., Tanavde, V., Lane, E. B., & Sampath, P. (2013) · Nature · doi:10.1038/nature11890 · Cited by 231
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
Wang, H., Jiang, Y., Peng, H., Chen, Y., Zhu, P., & Huang, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.031 · Cited by 231
Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma
Wang, F., Li, L., Piontek, K., Sakaguchi, M., & Selaru, F. M. (2018) · Hepatology · doi:10.1002/hep.29586 · Cited by 231
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12951-0 · Cited by 227
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Forterre, A., Komuro, H., Aminova, S., & Harada, M. (2020) · Cancers · doi:10.3390/cancers12071852 · Cited by 227
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Wu, Y., Crawford, M., Mao, Y., Lee, R. J., Davis, I. C., Elton, T. S., Lee, L. J., & Nana-Sinkam, S. P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.14 · Cited by 223
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 215
Song, Y., Zhang, C., Zhang, J., Jiao, Z., Dong, N., Wang, G., Wang, Z., & Wang, L. (2019) · Theranostics · doi:10.7150/thno.29945 · Cited by 215
Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis
Zhou, Y., Li, P., Goodwin, A. J., Cook, J. A., Halushka, P. V., Chang, E., & Fan, H. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.020 · Cited by 211
Recent progress in microRNA-based delivery systems for the treatment of human disease
Fu, Y., Chen, J., & Huang, Z. (2019) · ExRNA · doi:10.1186/s41544-019-0024-y · Cited by 211
Equine Infectious Anemia Virus (EIAV): what has HIV?s country cousin got to tell us?
Leroux, C., Cador�, J.-L., & Montelaro, R. C. (2004) · Veterinary Research · doi:10.1051/vetres:2004020 · Cited by 202
Polyethylenimines for siRNA and miRNA delivery in vivo
Höbel, S., & Aigner, A. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1228 · Cited by 201
LIU, C.-G., SONG, J., ZHANG, Y.-Q., & WANG, P.-C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2484 · Cited by 201
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
Therapeutic potential for microRNAs
Esau, C. C., & Monia, B. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.007 · Cited by 195
Kheirolomoom, A., Kim, C. W., Seo, J. W., Kumar, S., Son, D. J., Gagnon, M. K. J., Ingham, E. S., Ferrara, K. W., & Jo, H. (2015) · ACS Nano · doi:10.1021/acsnano.5b02611 · Cited by 191
Qian, X., Long, L., Shi, Z., Liu, C., Qiu, M., Sheng, J., Pu, P., Yuan, X., Ren, Y., & Kang, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.039 · Cited by 186
Wen, D., Peng, Y., Liu, D., Weizmann, Y., & Mahato, R. I. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.044 · Cited by 180
Exosome-mimetic nanoplatforms for targeted cancer drug delivery
Vázquez-Ríos, A. J., Molina-Crespo, Á., Bouzo, B. L., López-López, R., Moreno-Bueno, G., & de la Fuente, M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0517-8 · Cited by 178
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells
Ghosh, R., Singh, L. C., Shohet, J. M., & Gunaratne, P. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.023 · Cited by 172
The Clinical Application of MicroRNAs in Infectious Disease
Drury, R. E., O’Connor, D., & Pollard, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01182 · Cited by 171
Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting
Gao, S., Chen, J., Xu, X., Ding, Z., Yang, Y.-H., Hua, Z., & Zhang, J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00082-6 · Cited by 166
Qiao, C., Yuan, Z., Li, J., He, B., Zheng, H., Mayer, C., Li, J., & Xiao, X. (2011) · Gene Therapy · doi:10.1038/gt.2010.157 · Cited by 163
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Nishimura, M., Jung, E.-J., Shah, M. Y., Lu, C., Spizzo, R., Shimizu, M., Han, H. D., Ivan, C., Rossi, S., Zhang, X., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0159 · Cited by 160
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2
Miyazaki, Y., Adachi, H., Katsuno, M., Minamiyama, M., Jiang, Y., Huang, Z., Doi, H., Matsumoto, S., Kondo, N., Iida, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2791 · Cited by 157
Construction and analysis of compact muscle-specific promoters for AAV vectors
Wang, B., Li, J., Fu, F. H., Chen, C., Zhu, X., Zhou, L., Jiang, X. L., & Xiao, X. (2008) · Gene Therapy · doi:10.1038/gt.2008.104 · Cited by 155
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Lee, T. J., Yoo, J. Y., Shu, D., Li, H., Zhang, J., Yu, J.-G., Jaime‐Ramirez, A. C., Acunzo, M., Romano, G., Cui, R., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.016 · Cited by 151
Bertucci, A., Prasetyanto, E. A., Septiadi, D., Manicardi, A., Brognara, E., Gambari, R., Corradini, R., & Cola, L. D. (2015) · Small · doi:10.1002/smll.201500540 · Cited by 150
An overview of viral and nonviral delivery systems for microRNA
Yang, N. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167646 · Cited by 149
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
Li, M., Zhang, W., Wang, B., Gao, Y., Song, Z., & Zheng, Q. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s115727 · Cited by 149
Piao, L., Zhang, M., Datta, J., Xie, X., Su, T., Li, H., Teknos, T. N., & Pan, Q. (2012) · Molecular Therapy · doi:10.1038/mt.2012.67 · Cited by 146
Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles
Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J., & Wang, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08512.x · Cited by 129
Rai, K., Takigawa, N., Ito, S., Kashihara, H., Ichihara, E., Yasuda, T., Shimizu, K., Tanimoto, M., & Kiura, K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0220 · Cited by 129
Mangeot, P.-E., Négre, D., Dubois, B., Winter, A. J., Leissner, P., Mehtali, M., Kaiserlian, D., Cosset, F., & Darlix, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8307-8315.2000 · Cited by 129
Li, Y., Duo, Y., Bi, J., Zeng, X., Mei, L., Bao, S., He, L., Shan, A., Zhang, Y., & Yu, X. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158290 · Cited by 129
Therapeutic miRNA-Enriched Extracellular Vesicles: Current Approaches and Future Prospects
Munir, J., Yoon, J. K., & Ryu, S. (2020) · Cells · doi:10.3390/cells9102271 · Cited by 128
Gao, S., Tian, H., Guo, Y., Li, Y., Guo, Z., Zhu, X., & Chen, X. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.07.020 · Cited by 123
Li, D., Huang, S., Yin, Z., Zhu, J., Ge, X., Han, Z., Tan, J., Zhang, S., Zhao, J., Chen, F., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02825-1 · Cited by 121
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G. S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K. B., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 119
Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia
Endo‐Takahashi, Y., Negishi, Y., Nakamura, A., Ukai, S., Ooaku, K., Oda, Y., Sugimoto, K., Moriyasu, F., Takagi, N., Suzuki, R., et al. (2014) · Scientific Reports · doi:10.1038/srep03883 · Cited by 115
Peptide-mediated intracellular delivery of miRNA-29b for osteogenic stem cell differentiation
Suh, J. S., Lee, J., Choi, Y., Chong, P. C., & Park, Y. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.039 · Cited by 114
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma
Seo, Y.-E., Suh, H., Bahal, R., Josowitz, A. D., Zhang, J., Song, E., Cui, J., Noorbakhsh, S. I., Jackson, C. B., Bu, T., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.02.016 · Cited by 114
Ortega, A., Martínez-Arroyo, O., Forner, M. J., & Cortés, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010003 · Cited by 114
Zhang, H., Bai, M., Deng, T., Liu, R., Wang, X., Qu, Y., Duan, J., Zhang, L., Ning, T., Ge, S., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.026 · Cited by 113
Kobayashi, M., Sawada, K., Miyamoto, M., Shimizu, A., Yamamoto, M., Kinose, Y., Nakamura, K., Kawano, M., Kodama, M., Hashimoto, K., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.076 · Cited by 112
Jia, C., Chen, H., Wei, M., Chen, X., Zhang, Y., Cao, L., Yuan, P., Wang, F., Yang, G., & Ma, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138400 · Cited by 106
The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
Shaik, M. M., Tamargo, I., Abubakar, M., Kamal, M., Greig, N., & Gan, S. (2018) · Genes · doi:10.3390/genes9040174 · Cited by 105
Ye, D., Wang, G., Liu, Y., Huang, W., Wu, M., Zhu, S., Jia, W., Deng, A., Liu, H., & Kang, J. (2012) · Stem Cells · doi:10.1002/stem.1149 · Cited by 104
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
Pan, Y., Jia, Zhang, Zhang, Zhang, Li, & Wang, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37990 · Cited by 103
Systemic Delivery of microRNA‐34a for Cancer Stem Cell Therapy
Shi, S., Han, L., Gong, T., Zhang, Z., & Sun, X. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208077 · Cited by 100
Poeschla, E. M., Gilbert, J., Li, X., Huang, S., Ho, A. D., & Wong‐Staal, F. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6527-6536.1998 · Cited by 100
Hiraki, M., Nishimura, J., Takahashi, H., Wu, X., Takahashi, Y., Miyo, M., Nishida, N., Uemura, M., Hata, T., Takemasa, I., et al. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.5 · Cited by 97
Li, X., Liu, L. L., Yao, J. L., Wang, K., & Ai, H. (2019) · Stem Cells International · doi:10.1155/2019/8108576 · Cited by 94
Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing
Cheng, C. J., & Saltzman, W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300081s · Cited by 92
Salzano, G., Costa, D. F. G., Sarısözen, C., Luther, E., Mattheolabakis, G., Pooja, P. D., & Torchilin, V. P. (2016) · Small · doi:10.1002/smll.201600925 · Cited by 92
Non-viral based miR delivery and recent developments
Labatut, A. E., & Mattheolabakis, G. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.018 · Cited by 92
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Glover, A. R., Zhao, J., Gill, A. J., Weiss, J., Amaro-Mugridge, N. B., Kim, E., Feeney, A. L., Ip, J. C. Y., Reid, G., Clarke, S. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5383 · Cited by 88
Kasar, S. N., Salerno, E., Yuan, Y., Underbayev, C., Vollenweider, D., Laurindo, M. F. L., Fernandes, H., Bonci, D., Addario, A., Mazzella, F. M., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.58 · Cited by 87
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
Williams, M., Kirschner, M. B., Cheng, Y. Y., Hanh, J., Weiss, J., Amaro-Mugridge, N. B., Wright, C. M., Linton, A., Kao, S., Edelman, J. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4346 · Cited by 85
Berkowitz, R. D., Ilves, H., Lin, W., Eckert, K., Coward, A., Tamaki, S. J., Veres, G., & Plavec, I. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3371-3382.2001 · Cited by 83
A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA
Zhang, T., Xue, X., He, D., & Hsieh, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.003 · Cited by 80
miRNA-720 Controls Stem Cell Phenotype, Proliferation and Differentiation of Human Dental Pulp Cells
Hara, E. S., Ono, M., Eguchi, T., Kubota, S., Pham, H. T., Sonoyama, W., Tajima, S., Takigawa, M., Calderwood, S. K., & Kuboki, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083545 · Cited by 80
Wang, F., Zhang, B., Zhou, L. M., Shi, Y., Li, Z., Xia, Y., & Tian, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02662 · Cited by 80
Gao, S., Chen, J., Dong, L., Ding, Z., Yang, Y., & Zhang, J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.011 · Cited by 79
Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
Gokita, K., Inoue, J., Ishihara, H., Kojima, K., & Inazawa, J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.045 · Cited by 79
Delivery of therapeutic miRNA using polymer-based formulation
Ban, E., Kwon, T.-H., & Kim, A. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00645-y · Cited by 77
Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
Schade, A., Delyagina, E., Scharfenberg, D., Skorska, A., Lux, C. A., David, R., & Steinhoff, G. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610710 · Cited by 76
Teegala, L. R., Garikapati, K. R., Reddy, S. G., Reddy, B. V. S., Yadav, J. S., Bhadra, U., & Bhadra, M. P. (2016) · Scientific Reports · doi:10.1038/srep35223 · Cited by 76
microRNA inhibitors: Natural and artificial sequestration of microRNA
Tang, L., Chen, H., Hao, N.-B., Tang, B., Guo, H., Yong, X., Dong, H. F., & Yang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.025 · Cited by 76
MicroRNAs and Long Non-coding RNAs in Genetic Diseases
Finotti, A., Fabbri, E., Lampronti, I., Gasparello, J., Borgatti, M., & Gambari, R. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0380-6 · Cited by 76
Protecting microRNAs from RNase degradation with steric DNA nanostructures
Qian, H., Tay, C. Y., Setyawati, M. I., Chia, S. L., Lee, D. S., & Leong, D. T. (2016) · Chemical Science · doi:10.1039/c6sc01829g · Cited by 74
Potential therapeutic applications of exosomes in different autoimmune diseases
Xu, H. M., Jia, S., & Xu, H. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.06.006 · Cited by 73
Wang, G., Jia, T., Xu, X., Chang, L., Zhang, R., Fu, Y., Li, Y., Yang, X., Zhang, K., Lin, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10681 · Cited by 71
Lentiviral Delivery of miR-133b Improves Functional Recovery After Spinal Cord Injury in Mice
Theis, T., Yoo, M., Park, C. S., Chen, J., Kügler, S., Gibbs, K. M., & Schachner, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0007-z · Cited by 70
Instability of miRNA and cDNAs derivatives in RNA preparations
Bravo-Egaña, V., Rosero, S., Ricordi, C., & Pastori, R. L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.135 · Cited by 68
Xu, F., Liao, J., Xiang, G., Zhao, P., Ye, F., Zhao, Q., & He, X. (2017) · Cancer Medicine · doi:10.1002/cam4.1016 · Cited by 68
Vandenberghe, L. H., & Wilson, J. M. (2007) · Current Gene Therapy · doi:10.2174/156652307782151416 · Cited by 67
Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene
Gasparello, J., Manicardi, A., Casnati, A., Corradini, R., Gambari, R., Finotti, A., & Sansone, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-39211-4 · Cited by 66
Luarte, A., Henzi, R., Fernández, A., Gaete, D., Cisternas, P., Pizarro, M., Bátiz, L. F., Villalobos, I., Masalleras, M., Vergara, R. C., et al. (2020) · Cells · doi:10.3390/cells9040930 · Cited by 66
Retrovirus and lentivirus vector design and methods of cell conditioning
Cooray, S., Howe, S. J., & Thrasher, A. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00003-x · Cited by 65
Toolbox for retrovectorologists
Pagès, J., & Bru, T. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.498 · Cited by 60
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
Martier, R., Sogorb-González, M., Stricker-Shaver, J., Hübener‐Schmid, J., Keskin, S., Klíma, J., Toonen, L. J. A., Juhás, Š., Juhásová, J., Ellederová, Z., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.10.008 · Cited by 59
Ye, X., Liu, Z., Hemida, M. G., & Yang, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021215 · Cited by 55
Sun, X. H., Guo, Q., Wei, W., Robertson, S. P., Yuan, Y., & Luo, X. (2019) · International Journal of Endocrinology · doi:10.1155/2019/6782653 · Cited by 51
Lentiviral vector integration sites in human NOD/SCID repopulating cells
Laufs, S., Güenechea, G., González‐Murillo, Á., Nagy, K. Z., Lozano, M. L., del Val, C., Jonnakuty, S., Hotz‐Wagenblatt, A., Zeller, W. J., Bueren, J. A., et al. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.958 · Cited by 49
Bikram, M., Lee, M., Chang, C., Janat-Amsbury, M.-M., Kern, S. E., & Kim, S. W. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.011 · Cited by 48
miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis
McCoy, C. E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5987-2_5 · Cited by 46
Hu, Q., Wang, K., Sun, X. D., Li, Y., Fu, Q., Liang, T., & Tang, G. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.016 · Cited by 45
Sun, S., Wang, Y., Zhou, R., Deng, Z., Han, Y., Han, X., Tao, W., Yang, Z., Shi, C., Hong, D., et al. (2017) · Theranostics · doi:10.7150/thno.16357 · Cited by 44
Dietary delivery: a new avenue for microRNA therapeutics?
Hirschi, K. D., Pruss, G. J., & Vance, V. B. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.06.003 · Cited by 42
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
Yao, Y., Jia, T., Pan, Y., Gou, H., Li, Y., Sun, Y., Zhang, R., Zhang, K., Lin, G., Xie, J., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048337 · Cited by 42
PEGylated cationic liposome–DNA complexation in brine is pathway-dependent
Silva, B. F. B., Majzoub, R. N., Chan, C.-L., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.09.008 · Cited by 42
Enhanced and synergistic downregulation of oncogenic miRNAs by self-assembled branched DNA
Nahar, S., Nayak, A. K., Ghosh, A., Subudhi, U., & Maiti, S. (2017) · Nanoscale · doi:10.1039/c7nr06601e · Cited by 41
Inoue, A., Mizushima, T., Wu, X., Okuzaki, D., Kambara, N., Ishikawa, S., Wang, J., Qian, Y., Hirose, H., Yokoyama, Y., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0850 · Cited by 41
Chitosan-Based Nanoparticles for Mucosal Delivery of RNAi Therapeutics
Martirosyan, A. S., Olesen, M. T. J., & Howard, K. A. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00011-0 · Cited by 40
Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma
Huang, X., Wu, W., Yang, W., Qing, X., & Shao, Z. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110891 · Cited by 40
Antonellis, P. D., Liguori, L., Falanga, A., Carotenuto, M., Ferrucci, V., Andolfo, I., Marinaro, F., Scognamiglio, I., Virgilio, A., Rosa, G. D., et al. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0837-4 · Cited by 39
Avcı, Ç. B., Özcan, İ., Balcı, T., Özer, Ö., & Gündüz, C. (2013) · Cell Biology International · doi:10.1002/cbin.10157 · Cited by 38
Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®
de Almeida, S. S. T., Horst, C. H., Soto‐Sánchez, C., Fernández, E., & Titze‐de‐Almeida, R. (2018) · Molecules · doi:10.3390/molecules23071825 · Cited by 37
Kalle, C. V., Fehse, B., Layh‐Schmitt, G., Schmidt, M., Kelly, P. F., & Baum, C. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.07.007 · Cited by 33
Soto‐Sánchez, C., Martı́nez, G., Humphreys, L., Puras, G., Sesma, J. Z., Pedraz, J. L., & Fernández, E. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.01.012 · Cited by 33
Nanobody-guided targeted delivery of microRNA via nucleic acid nanogel to inhibit the tumor growth
Zhang, Q., Ding, F., Liu, X., Shen, J., Su, Y., Qian, J., Zhu, X., & Zhang, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.058 · Cited by 33
Sun, Y., Sun, Y., & Zhao, R. (2017) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2017.03.012 · Cited by 31
Guo, P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-858-7:285 · Cited by 30
Yin, L., Keeler, G. D., Zhang, Y., Hoffman, B. E., Ling, C., Qing, K., & Srivastava, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0140-1 · Cited by 30
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle
Gasparello, J., Lomazzi, M., Papi, C., D’Aversa, E., Sansone, F., Casnati, A., Donofrío, G., Gambari, R., & Finotti, A. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.029 · Cited by 29
Design and synthesis of dual-ligand modified chitosan as a liver targeting vector
Chen, H., Li, M., Wan, T. Y., Zheng, Q., Cheng, M., Huang, S., & Wang, Y. (2011) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-011-4494-1 · Cited by 28
Cho, W. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.57 · Cited by 28
Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA
Wilner, S. E., & Levy, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_18 · Cited by 28
Antiviral Effects of Inhibiting Host Gene Expression
Tripp, R. A., & Tompkins, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_409 · Cited by 19
Tang, X., Zhang, H., Song, Y., Zhou, D., & Wang, J. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.25 · Cited by 16
Pourshafie, N., Lee, P. R., Chen, K., Harmison, G. G., Bott, L. C., Fischbeck, K. H., & Rinaldi, C. (2018) · Journal of Visualized Experiments · doi:10.3791/55724 · Cited by 14
Cited by
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 971
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
miRNA: A Promising Therapeutic Target in Cancer
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911502 · Cited by 357
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Momin, M. Y., Gaddam, R. R., Kravitz, M., Gupta, A., & Vikram, A. (2021) · Cells · doi:10.3390/cells10113097 · Cited by 107
Metadata
- Authors
- Dasgupta, I., & Chatterjee, A.
- Venue
- Methods and Protocols
- Publisher
- MDPI AG
- Published
- 2021-01-20
- Volume
- 4
- Issue
- 1
- Pages
- 10
- ISSN
- 2409-9279 (ISSN-L)
- OpenAlex
- W3125907883
- Cited by
- 307
- References
- 172
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.